AXXCESS WEALTH MANAGEMENT, LLC
Position in SLS — SELLAS Life Sciences Group, Inc.
CIK 1911056
CARLSBAD, CA
Position in SLS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$610,665
+$461,050 QoQ
Shares Held
41,373
+17.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#79
of 189 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AXXCESS WEALTH MANAGEMENT, LLC holds $9,457,652 across 14 Biotechnology names. SLS ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DYN |
Dyne Therapeutics, Inc.
|
155,270 | $3,448,546 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
14,515 | $1,381,392 | |
| 3 | ASND |
Ascendis Pharma A/S
|
3,842 | $1,024,738 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
14,114 | $769,777 | |
| 5 | SLS |
SELLAS Life Sciences Group, Inc.
This page
|
41,373 | $610,665 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,074 | $533,488 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
6,269 | $510,986 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
22,707 | $384,202 |
All Filings in SLS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $610,665 | 41,373 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $149,615 | 35,370 | Shares | Sole | 2026-04-29 | |
| 2025-09-30 | $25,760 | 16,000 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||